Evotec International GmbH secures contract for Research and Experimental Development Services - Development of an inhibitor for a new therapeutic target (Hit to Lead)

Posted On: 2025-11-13

France, Nov. 13 -- France based Evotec International GmbH has secured contract from INSTITUT CURIE for Research and Experimental Development Services - Development of an inhibitor for a new therapeutic target (Hit to Lead). The value of the contract is worth 28250000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Evotec International GmbH secures contract for Research and Experimental Development Services - Development of an inhibitor for a new therapeutic target (Hit to Lead)